AU2700895A - Human vascular endothelial growth factor 3 - Google Patents
Human vascular endothelial growth factor 3Info
- Publication number
- AU2700895A AU2700895A AU27008/95A AU2700895A AU2700895A AU 2700895 A AU2700895 A AU 2700895A AU 27008/95 A AU27008/95 A AU 27008/95A AU 2700895 A AU2700895 A AU 2700895A AU 2700895 A AU2700895 A AU 2700895A
- Authority
- AU
- Australia
- Prior art keywords
- growth factor
- vascular endothelial
- endothelial growth
- human vascular
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007283 WO1996039421A1 (en) | 1995-06-06 | 1995-06-06 | Human vascular endothelial growth factor 3 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27806/00A Division AU2780600A (en) | 1995-06-06 | 2000-04-17 | Human vascular endothelial growth factor 3 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2700895A true AU2700895A (en) | 1996-12-24 |
AU716100B2 AU716100B2 (en) | 2000-02-17 |
Family
ID=22249276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27008/95A Ceased AU716100B2 (en) | 1995-06-06 | 1995-06-06 | Human vascular endothelial growth factor 3 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2001509001A (en) |
KR (1) | KR19990022317A (en) |
AU (1) | AU716100B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102143208B1 (en) | 2018-09-13 | 2020-08-12 | 주식회사 케이씨티 | Load Port Module and Load Purge Purge System Having Air Curtain Unit |
-
1995
- 1995-06-06 AU AU27008/95A patent/AU716100B2/en not_active Ceased
- 1995-06-06 JP JP50037897A patent/JP2001509001A/en not_active Ceased
- 1995-06-06 KR KR1019970708797A patent/KR19990022317A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU716100B2 (en) | 2000-02-17 |
KR19990022317A (en) | 1999-03-25 |
MX9709570A (en) | 1998-03-29 |
JP2001509001A (en) | 2001-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0871705A4 (en) | Human ccn-like growth factor | |
AU7458596A (en) | Vascular stent | |
AU665899B2 (en) | Artificial heart | |
AU7621794A (en) | Vascular prostheses | |
AU673995B2 (en) | Vascular stent | |
AU5439998A (en) | Vascular endothelial growth factor | |
AUPN174495A0 (en) | Surgical prostheses | |
AU1684595A (en) | Biocompatible implants | |
AU694822B2 (en) | Biocompatible medical lead | |
AU5095196A (en) | Medical implants | |
EP0744162A3 (en) | Textile surgical implants | |
AU1271597A (en) | Modular physiological computer-recorder | |
AU4102793A (en) | Novel soft tissue implants | |
AU5437396A (en) | Bileaflet heart valve | |
EP1062319A4 (en) | Vascular endothelial growth factor 2 | |
GB9510967D0 (en) | Vascular prostheses | |
AU4693093A (en) | Biocompatible surgical implant | |
EP0873348A4 (en) | Human vascular endothelial growth factor 3 | |
AU2643292A (en) | Biological tissue adhesion | |
AU5363596A (en) | Biocompatible materials | |
AU3011497A (en) | Novel human growth factors | |
AU1350797A (en) | Artificial skin construction | |
AU2653095A (en) | Fibroblast growth factor-14 | |
AU2653195A (en) | Fibroblast growth factor 11 | |
AU2697995A (en) | Fibroblast growth factor 13 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CB | Opposition lodged by |
Opponent name: GENENTECH, INC |
|
CC1 | Opposition dismissed - proceed to grant |
Opponent name: GENENTECH INC |
|
FGA | Letters patent sealed or granted (standard patent) |